DOI:
10.1055/s-00034915
Onkologische Welt
LinksClose Window
References
Tie J. et al
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.
JAMA Oncol 2019 doi:10.1001/jamaoncol.2019.3616
Access:
We do not assume any responsibility for the contents of the web pages of other providers.